Fundz

AnaptysBio Appoints Christopher Murphy as Chief Financial Officer

PUBLIC · ANABMay 11, 2026

Position

Chief Financial Officer

Company

ANAPTYSBIO INC

Christopher Murphy
San DiegoBiotechnologyHealth CareTherapeutics

Description

AnaptysBio, Inc. has announced the appointment of Christopher Murphy as Chief Financial Officer, enhancing its leadership team with his extensive experience in finance and business development. This addition aims to strengthen the company's focus on maximizing shareholder value.

Quick answer

AnaptysBio Appoints Christopher Murphy as Chief Financial Officer (May 11, 2026). ANAPTYSBIO INC is based in San Diego, California, United States.

Who is the new Chief Financial Officer at ANAPTYSBIO INC?
ANAPTYSBIO INC named Christopher Murphy Chief Financial Officer, announced May 11, 2026.
What did ANAPTYSBIO INC announce on May 11, 2026?
AnaptysBio, Inc. has announced the appointment of Christopher Murphy as Chief Financial Officer, enhancing its leadership team with his extensive experience in finance and business development. This addition aims to strengthen the company's focus on maximizing shareholder value.
What does ANAPTYSBIO INC do?
AnaptysBio develops antibody therapeutics based on somatic hypermutation.
Where is ANAPTYSBIO INC based?
ANAPTYSBIO INC is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Zura Bio (May 13, 2026), Infinimmune (May 13, 2026), OnCusp Therapeutics (May 14, 2026) and Menarini Group (May 7, 2026) also announced leadership changes within 45 days of ANAPTYSBIO INC.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ANAPTYSBIO INC, and when

A new leader at ANAPTYSBIO INC brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ANAPTYSBIO INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ANAPTYSBIO INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ANAPTYSBIO INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ANAPTYSBIO INC

Location

San Diego, California, United States

About

AnaptysBio develops antibody therapeutics based on somatic hypermutation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ANAPTYSBIO INC changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Paul
Senior decision-maker at this company
••••••••@••••••••

See Paul's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ANAPTYSBIO INC's next move

Learn about Strategic plan

ANAPTYSBIO INC changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.